Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.090
-0.020 (-1.80%)
At close: Jul 2, 2026, 4:00 PM EDT
1.097
+0.007 (0.63%)
After-hours: Jul 2, 2026, 6:23 PM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $16.14 million as of July 2, 2026. Its market cap has decreased by -42.36% in one year.
Market Cap
16.14M
Enterprise Value
22.19M
1-Year Change
-42.36%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $16.14M, a decrease of -81.79%. That is a compound annual growth rate of -28.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 16.14M | 14.13% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GT Biopharma | 17.82M |
| Atossa Therapeutics | 17.57M |
| Celularity | 17.49M |
| Werewolf Therapeutics | 17.15M |
| Curis | 16.88M |
| Citius Pharmaceuticals | 16.72M |
| BioVie | 16.44M |
| CalciMedica | 16.43M |